✦ LIBER ✦

Agentic extraversion modulates the cardiovascular effects of the dopamine D2 agonist bromocriptine

✍ Scribed by Jan Wacker; Gerhard Stemmler

Book ID: 111136013
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 245 KB
Volume: 43
Category: Article
ISSN: 0048-5772
DOI: 10.1111/j.1469-8986.2006.00417.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Electroncytochemical studies of cardiac

Electroncytochemical studies of cardiac effects of dopamine and D-2 agonist, bromocriptine

✍ Zs. Kertesz; V. Kecskemeti; I. Balogh 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 102 KB

Therapeutic effect of the D2-dopamine ag

Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis

✍ C.D. Dijkstra; E.Rouppe van der Voort; C.J.A. De Groot; I. Huitinga; B.M.J. Uitd 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 522 KB

The dopamine D2 receptor agonists, quinp

The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences

✍ Hoffman, Diane C.; Dickson, Patricia R.; Ricahrd J., Beninger 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 448 KB

Modulation of Inhibition of Return by th

Modulation of Inhibition of Return by the Dopamine D2 Receptor Agonist Bromocriptine Depends on Individual DAT1 Genotype

✍ Rokem, A.; Landau, A. N.; Prinzmetal, W.; Wallace, D. L.; Silver, M. A.; D'Espos 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 244 KB

Attenuation of the locomotor-sensitizing

Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride

✍ Roy A. Wise; William A. Carlezon Jr. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Injections of the selective D, dopamine agonist bromocriptine (5.0 mg/ kg, IP) produced progressively stronger locomotion over 10 days of repeated testing. Concurrent treatment with either the D, antagonist SCH 23390 (0.01 or 0.1 mg/kg, IP) or the D, antagonist raclopride (0.1 or 1.0 mg/kg, IP) supp

Cortical effects of bromocriptine, a D-2

Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI

✍ Daniel Y. Kimberg; Geoffrey K. Aguirre; Jessica Lease; Mark D'Esposito 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

Studies of human subjects performing cognitive tasks on and off dopaminergic drugs have suggested a specific role of dopamine in cognitive processes, particularly in working memory and prefrontal "executive" functions. However, the cortical effects of these drugs have been poorly understood. We used